Dr. Shaji Kumar, Prof. of Medicine, Mayo Clinic, USA

HealthTree Podcast for Multiple Myeloma: Dr. Shaji Kumar, Mayo ClinicПодробнее

HealthTree Podcast for Myeloma: Shaji Kumar, MD, Mayo Clinic on ETBs in MyelomaПодробнее

Cancer News Interview with Dr. Shaji KumarПодробнее

Additional Advances in Multiple Myeloma Research and Clinical Trials With Shaji Kumar, MDПодробнее

Dr. Shaji Kumar - Mayo Clinic - Rochester, USAПодробнее

Shaji Kumar on Recent Clinical Trial Developments in MyelomaПодробнее

Shaji Kumar on the Changing Immunotherapy Landscape in MyelomaПодробнее

ASH 2020 - Highlights in MyelomaПодробнее

ASH 2020: Targeted therapies in r/r multiple myelomaПодробнее

Basics of MGUS and Smoldering Myeloma - Shaji Kumar, MD | MCRT Webcast September 26 (1/3)Подробнее

A Look at the Multiple Myeloma PipelineПодробнее

Dr. Kumar: Results of the ENDURANCE Trial Support Standard of Care Treatment for MyelomaПодробнее

Advances in Multiple Myeloma, Dr. Shaji Kumar, Mayo Clinic USAПодробнее

Dr. Kumar on Stem Cell Mobilization in Multiple MyelomaПодробнее

Shaji Kumar, MD, provides perspective on the role of anti-CD38 antibodies changing multiple myelomaПодробнее

Shaji Kumar, MD, shares the design and outcomes of the CARTITUDE-1 trial regarding multiple myelomaПодробнее

Shaji Kumar, MD, shares the take home message for physicians treating 1st line multiple myelomaПодробнее

Shaji Kumar, ASCO20: Efficacy and Toxicity in the Randomised Phase III ENDURANCE Trial in MyelomaПодробнее

Shaji Kumar, MD, shares results of the Phase 3 study regarding 1st line multiple myeloma treatmentПодробнее

Relapse Refractory Multiple Myeloma: Real World Experience, Dr. Shaji Kumar, Mayo Clinic, USAПодробнее